For evaluation of drugs and screening of potential inhibitors to chymotrypsin proteases. Safe. Non-radioactive assay. Homogeneous and convenient. Homogenous ''Mix-incubate-measure type assay. No wash and reagent transfer steps are involved. Robust and High-throughput. Can be readily automated to assay thousands of samples per day. Robust assay with a Z factor of >0.8. Method: FL485/530 nm, Samples: Compounds that affect chymotrypsin protease activity. Species: All, Procedures: 45 min.
DCTI-100
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
